| 1 | Chondrosarcoma | 31.6% |
| 2 | leiomyosarcoma | 31.6% |
| 3 | liposarcoma | 31.6% |
| 4 | synovial sarcoma | 31.6% |
| 5 | Clear Cell Sarcoma of Soft Tissue | 31.6% |
| 6 | Alveolar Soft Part Sarcoma | 31.6% |
| 7 | Carcinoma 256, Walker | 31.2% |
| 8 | Carcinosarcoma | 30.2% |
| 9 | Hemangiosarcoma | 30.2% |
| 10 | lymphangiosarcoma | 30.2% |
| 11 | Fibrosarcoma | 28.2% |
| 12 | Osteosarcoma | 28.2% |
| 13 | Phyllodes Tumor | 27.6% |
| 14 | Desmoplastic Small Round Cell Tumor | 27.6% |
| 15 | Sarcoma, Myeloid | 26.7% |
| 16 | Malignant Fibrous Histiocytoma | 26.6% |
| 17 | Carcinoma, Ehrlich Tumor | 24.9% |
| 18 | Carcinoma, Lewis Lung | 24.9% |
| 19 | Leukemia, Experimental | 22.6% |
| 20 | Angiomyolipoma | 21.9% |
| 21 | leukemia | 21.8% |
| 22 | Neoplasms, Germ Cell and Embryonal | 21.8% |
| 23 | Neoplasms, Glandular and Epithelial | 21.8% |
| 24 | Germ Cell Cancer | 21.8% |
| 25 | Rhabdomyosarcoma | 21.7% |
| 26 | Hamartoma | 21.6% |
| 27 | Neoplasms, Hormone-Dependent | 21.6% |
| 28 | Neoplasms, Multiple Primary | 21.6% |
| 29 | Paraneoplastic Syndromes | 21.6% |
| 30 | Precancerous Conditions | 21.6% |
| 31 | Neoplasms, Second Primary | 21.6% |
| 32 | Dermatofibrosarcoma | 20% |
| 33 | Dermatofibrosarcoma Protuberans | 20% |
| 34 | Mammary Neoplasms, Experimental | 19.3% |
| 35 | Neuroectodermal Tumors | 18.9% |
| 36 | Melanoma, Experimental | 18.1% |
| 37 | Leukemia L1210 | 18% |
| 38 | Leukemia P388 | 18% |
| 39 | Neoplasms, Neuroepithelial | 17.3% |
| 40 | Gliomatosis cerebri | 17.3% |
| 41 | Alveolar rhabdomyosarcoma | 16.8% |
| 42 | Histiocytic Disorders, Malignant | 16.3% |
| 43 | Cyst | 16.3% |
| 44 | Neoplastic Processes | 16.3% |
| 45 | Neoplastic Syndromes, Hereditary | 16.3% |
| 46 | Pregnancy Complications, Neoplastic | 16.3% |
| 47 | Endometrial Stromal Sarcoma | 15.5% |
| 48 | Giant Cell Tumor of Bone | 15.3% |
| 49 | Dermoid Cyst | 14.9% |
| 50 | Trophoblastic Neoplasms | 14.7% |
| 51 | Lipoma | 14.6% |
| 52 | Myoma | 14.6% |
| 53 | Myxoma | 14.6% |
| 54 | Angiolipoma | 14.6% |
| 55 | Myelolipoma | 14.6% |
| 56 | Neoplasms, Bone Tissue | 14.6% |
| 57 | Neoplasms, Fibrous Tissue | 14.6% |
| 58 | Smooth Muscle Tumor | 14.6% |
| 59 | Chondroma | 14.6% |
| 60 | Enchondroma | 14.6% |
| 61 | melanoma | 14.6% |
| 62 | Meningioma | 14.4% |
| 63 | Neurofibrosarcoma | 13.9% |
| 64 | Multiple Endocrine Neoplasia | 13.4% |
| 65 | Lymphoma | 13% |
| 66 | Neoplasms, Radiation-Induced | 12.8% |
| 67 | Liver Neoplasms, Experimental | 12.8% |
| 68 | Adenoma | 12.6% |
| 69 | Ameloblastoma | 12.6% |
| 70 | Angiokeratoma | 12.6% |
| 71 | Carcinoma | 12.6% |
| 72 | Chordoma | 12.6% |
| 73 | Hemangioma | 12.6% |
| 74 | hemangiopericytoma | 12.6% |
| 75 | Lymphangioma | 12.6% |
| 76 | Mesenchymoma | 12.6% |
| 77 | Nevus | 12.6% |
| 78 | Teratoma | 12.6% |
| 79 | Hepatoblastoma | 12.6% |
| 80 | Mixed Tumor, Mullerian | 12.6% |
| 81 | Germinoma | 12.6% |
| 82 | Teratocarcinoma | 12.6% |
| 83 | Angiofibroma | 12.6% |
| 84 | Epithelioma | 12.6% |
| 85 | Composite Lymphoma | 12.5% |
| 86 | Leukemia, Plasma Cell | 12.4% |
| 87 | Leukemia, Radiation-Induced | 12.3% |
| 88 | Basal cell carcinoma | 12.1% |
| 89 | Carcinoma, Papillary | 12.1% |
| 90 | Squamous cell carcinoma | 12.1% |
| 91 | Craniopharyngioma | 12.1% |
| 92 | Cystadenoma | 12.1% |
| 93 | Mesothelioma | 12.1% |
| 94 | Neuroectodermal Tumor, Melanotic | 12.1% |
| 95 | Neuroendocrine Tumors | 12.1% |
| 96 | Carcinoma, Basal Cell | 12.1% |
| 97 | Adenofibroma | 12.1% |
| 98 | Fibroadenoma | 12.1% |
| 99 | Adenoma, Acidophil | 11.9% |
| 100 | Ganglioneuroma | 11.9% |
| 101 | Glioma | 11.9% |
| 102 | Malignant Glioma | 11.9% |
| 103 | Abdominal Neoplasms | 11.7% |
| 104 | Erythroplasia | 11.7% |
| 105 | Follicular cyst | 11.7% |
| 106 | Head and Neck Neoplasms | 11.7% |
| 107 | Mucocele | 11.7% |
| 108 | Pilonidal Cyst | 11.7% |
| 109 | Soft Tissue Neoplasms | 11.7% |
| 110 | Thoracic Neoplasms | 11.7% |
| 111 | Thyroglossal Cyst | 11.7% |
| 112 | Synovial Cyst | 11.7% |
| 113 | Aberrant Crypt Foci | 11.7% |
| 114 | Medulloblastoma | 11.5% |
| 115 | Paraneoplastic Encephalomyelitis | 11.5% |
| 116 | Acanthoma | 11.4% |
| 117 | Lymphangioleiomyomatosis | 11.3% |
| 118 | Carcinoid Tumor | 10.6% |
| 119 | Neurilemmoma | 10.6% |
| 120 | Hutchinson's Melanotic Freckle | 10.6% |
| 121 | Melanoma, Amelanotic | 10.6% |
| 122 | Choriocarcinoma | 10.5% |
| 123 | Carcinoma, Lobular | 10.5% |
| 124 | Thymoma | 10.5% |
| 125 | Cystadenocarcinoma | 10.5% |
| 126 | Mucoepidermoid Carcinoma | 10.5% |
| 127 | fibroma | 10.2% |
| 128 | Fibromatosis | 10.2% |
| 129 | Osteoblastoma | 10.2% |
| 130 | Osteoma | 10.2% |
| 131 | Rhabdomyoma | 10.2% |
| 132 | Chondromatosis | 10.2% |
| 133 | Tuberous Sclerosis | 9.7% |
| 134 | Plasmacytoma | 9.5% |
| 135 | Malignant histiocytosis | 9.4% |
| 136 | Histiocytic sarcoma | 9.4% |
| 137 | Astrocytoma | 9.3% |
| 138 | Ependymoma | 9.3% |
| 139 | oligodendroglioma | 9.3% |
| 140 | Ganglioglioma | 9.3% |
| 141 | gliosarcoma | 9.3% |
| 142 | Anaplastic astrocytoma | 9.3% |
| 143 | Anaplastic Oligodendroglioma | 9.3% |
| 144 | Digestive System Neoplasms | 9.3% |
| 145 | Endocrine Gland Neoplasms | 9.3% |
| 146 | Eye Neoplasms | 9.3% |
| 147 | Nervous System Neoplasms | 9.3% |
| 148 | Mastocytosis | 9% |
| 149 | Bone neoplasms | 8.9% |
| 150 | Leukoplakia | 8.9% |
| 151 | Lymphocele | 8.9% |
| 152 | Pancreatic Cyst | 8.9% |
| 153 | Skin Neoplasms | 8.9% |
| 154 | Hematologic Neoplasms | 8.9% |
| 155 | Gastrointestinal Stromal Tumors | 8.9% |
| 156 | Bowen's Disease | 8.8% |
| 157 | Paraganglioma | 8.8% |
| 158 | Barrett Esophagus | 8.8% |
| 159 | Breast Cyst | 8.8% |
| 160 | Actinic keratosis | 8.8% |
| 161 | Mediastinal Cyst | 8.8% |
| 162 | Neoplasm Invasiveness | 8.8% |
| 163 | Neoplasm Metastasis | 8.8% |
| 164 | Neoplasm Recurrence, Local | 8.8% |
| 165 | Parovarian Cyst | 8.8% |
| 166 | Pericardial Cyst | 8.8% |
| 167 | Splenic Neoplasms | 8.8% |
| 168 | Thymic Cyst | 8.8% |
| 169 | Carcinogenesis | 8.8% |
| 170 | Myxoid cyst | 8.8% |
| 171 | Metastasis | 8.8% |
| 172 | Lymphomatoid Granulomatosis | 8.7% |
| 173 | Malignant Carcinoid Syndrome | 8.6% |
| 174 | Retinoblastoma | 8.4% |
| 175 | Nephroblastoma | 8.3% |
| 176 | Multiple Endocrine Neoplasia Type 1 | 8.2% |
| 177 | Adenocarcinoma | 8.1% |
| 178 | Carcinoma in Situ | 8.1% |
| 179 | Carcinoma, Transitional Cell | 8.1% |
| 180 | Dysgerminoma | 8.1% |
| 181 | Hemangioendothelioma | 8.1% |
| 182 | Neuroma | 8.1% |
| 183 | Papilloma | 8.1% |
| 184 | Pseudomyxoma Peritonei | 8.1% |
| 185 | Seminoma | 8.1% |
| 186 | Papillomatosis | 8.1% |
| 187 | Adenomatosis, Pulmonary | 8.1% |
| 188 | Adenomatous Polyps | 8.1% |
| 189 | Carcinoma, Large Cell | 8.1% |
| 190 | Carcinoma, Small Cell | 8.1% |
| 191 | Fibromatosis, Aggressive | 8% |
| 192 | Fibromatosis, Abdominal | 8% |
| 193 | Glioblastoma | 8% |
| 194 | Neuroblastoma | 8% |
| 195 | Glioblastoma Multiforme | 8% |
| 196 | Mastocytoma | 7.7% |
| 197 | Mastocytosis, Systemic | 7.7% |
| 198 | Hodgkin Disease | 7.5% |
| 199 | Lymphoma, Non-Hodgkin | 7.5% |
| 200 | Basal Cell Nevus Syndrome | 7.4% |
| 201 | Neoplasms, Experimental | 7.4% |
| 202 | Parathyroid Neoplasms | 7.3% |
| 203 | Peritoneal Neoplasms | 7.3% |
| 204 | Thyroid Neoplasm | 7.3% |
| 205 | Thyroid carcinoma | 7.3% |
| 206 | Ganglioneuroblastoma | 7.3% |
| 207 | Pheochromocytoma | 7.2% |
| 208 | Retroperitoneal Neoplasms | 7.1% |
| 209 | Corpus Luteum Cyst | 7% |
| 210 | Ovarian Cysts | 7% |
| 211 | Carcinoma, Pancreatic Ductal | 6.9% |
| 212 | Hepatocellular Adenoma | 6.5% |
| 213 | Carcinoid Heart Disease | 6.5% |
| 214 | Hydatidiform Mole | 6.4% |
| 215 | Acoustic Neuroma | 6.4% |
| 216 | Pancreatic Neoplasm | 6.3% |
| 217 | Primary amyloidosis | 6.3% |
| 218 | Tracheal Neoplasms | 6.2% |
| 219 | Leukemia, Myelomonocytic, Chronic | 6.1% |
| 220 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 6.1% |
| 221 | Mesoblastic Nephroma | 6% |
| 222 | Leukoplakia, Oral | 6% |
| 223 | Paraneoplastic Cerebellar Degeneration | 6% |
| 224 | Choledochal Cyst | 5.9% |
| 225 | Adenoid Cystic Carcinoma | 5.9% |
| 226 | Adenocarcinoma, Clear Cell | 5.9% |
| 227 | Cholangiocarcinoma | 5.9% |
| 228 | Cervical Intraepithelial Neoplasia | 5.9% |
| 229 | Hemangioblastoma | 5.9% |
| 230 | Lymphoma, Extranodal NK-T-Cell | 5.9% |
| 231 | Peutz-Jeghers Syndrome | 5.8% |
| 232 | Vipoma | 5.7% |
| 233 | Optic Nerve Glioma | 5.6% |
| 234 | Adenomatous Polyposis Coli | 5.6% |
| 235 | Prolactinoma | 5.6% |
| 236 | Growth Hormone-Secreting Pituitary Adenoma | 5.6% |
| 237 | Mouth Neoplasms | 5.4% |
| 238 | Central Nervous System Neoplasms | 5.4% |
| 239 | Vascular Neoplasms | 5.4% |
| 240 | Thymus Neoplasms | 5.4% |
| 241 | Genital Neoplasms, Female | 5.3% |
| 242 | Pancreatic Pseudocyst | 5.3% |
| 243 | Lymphatic Metastasis | 5.3% |
| 244 | Neoplasms, Unknown Primary | 5.3% |
| 245 | Leukemic Infiltration | 5.3% |
| 246 | Breast Neoplasms, Male | 5.3% |
| 247 | Neoplasm Micrometastasis | 5.3% |
| 248 | Triple Negative Breast Neoplasms | 5.3% |
| 249 | Esophageal Neoplasms | 5.2% |
| 250 | Limbic Encephalitis | 5.1% |
| 251 | insulinoma | 5% |
| 252 | Sturge-Weber Syndrome | 5% |
| 253 | Dupuytren Contracture | 5% |
| 254 | Sarcoma, Experimental | 5% |
| 255 | Thyroid Nodule | 4.9% |
| 256 | Hemangioma, Cavernous | 4.9% |
| 257 | Urticaria Pigmentosa | 4.9% |
| 258 | Leukemia, T-Cell | 4.9% |
| 259 | Leukemia, B-Cell | 4.9% |
| 260 | granulosa cell tumor | 4.8% |
| 261 | Carcinoma, Ovarian Epithelial | 4.8% |
| 262 | neurofibroma | 4.8% |
| 263 | Klatskin Tumor | 4.8% |
| 264 | Lymphoma, Follicular | 4.8% |
| 265 | T-Cell Lymphoma | 4.8% |
| 266 | Mantle cell lymphoma | 4.8% |
| 267 | Waldenstrom Macroglobulinemia | 4.7% |
| 268 | Multiple Myeloma | 4.7% |
| 269 | Gastrinoma | 4.6% |
| 270 | Glucagonoma | 4.6% |
| 271 | Lambert-Eaton Myasthenic Syndrome | 4.6% |
| 272 | Testicular Neoplasms | 4.6% |
| 273 | Leukemia, Myeloid, Chronic-Phase | 4.4% |
| 274 | Adrenal Gland Neoplasms | 4.4% |
| 275 | Gastrointestinal Neoplasms | 4.4% |
| 276 | Genital Neoplasms, Male | 4.4% |
| 277 | Liver neoplasms | 4.4% |
| 278 | Uveal Neoplasms | 4.4% |
| 279 | Sarcoma | 4.4% |
| 280 | Urologic Neoplasms | 4.3% |
| 281 | Sebaceous Gland Neoplasms | 4.3% |
| 282 | Spinal Neoplasms | 4.3% |
| 283 | Bone Marrow Neoplasms | 4.3% |
| 284 | Leydig Cell Tumor | 4.3% |
| 285 | Polycystic Ovary Syndrome | 4.2% |
| 286 | Adrenocortical carcinoma | 4.1% |
| 287 | Sarcoma 180 | 4.1% |
| 288 | Opsoclonus-Myoclonus Syndrome | 4.1% |
| 289 | Denys-Drash Syndrome | 3.9% |
| 290 | Nasopharyngeal carcinoma | 3.8% |
| 291 | Meningeal Neoplasms | 3.7% |
| 292 | Renal Cell Carcinoma | 3.6% |
| 293 | Papillary Renal Cell Carcinoma | 3.6% |
| 294 | Myelitis, Transverse | 3.6% |
| 295 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3.5% |
| 296 | Leukemia, Large Granular Lymphocytic | 3.5% |
| 297 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3.5% |
| 298 | Lymphoma, T-Cell, Cutaneous | 3.5% |
| 299 | Lymphoma, AIDS-Related | 3.5% |
| 300 | Enteropathy-Associated T-Cell Lymphoma | 3.5% |
| 301 | Primary Effusion Lymphoma | 3.5% |
| 302 | Xeroderma Pigmentosum | 3.5% |
| 303 | Carcinoma, Endometrioid | 3.4% |
| 304 | Nose Neoplasms | 3.4% |
| 305 | Palatal Neoplasms | 3.3% |
| 306 | ovarian neoplasm | 3.1% |
| 307 | Ear Neoplasms | 3% |
| 308 | Eyelid Neoplasms | 3% |
| 309 | Lung Neoplasms | 3% |
| 310 | Pleural Neoplasms | 3% |
| 311 | Pituitary Adenoma | 3% |
| 312 | Pituitary Neoplasms | 3% |
| 313 | Cell Transformation, Viral | 3% |
| 314 | Brain Neoplasms | 3% |
| 315 | Salivary Gland Neoplasms | 3% |
| 316 | Spinal Cord Neoplasms | 3% |
| 317 | Tongue Neoplasms | 3% |
| 318 | Uterine Neoplasms | 2.9% |
| 319 | Vaginal Neoplasms | 2.9% |
| 320 | Vulvar Neoplasms | 2.9% |
| 321 | Uterine Cancer | 2.9% |
| 322 | Fallopian Tube Neoplasms | 2.9% |
| 323 | Mycosis Fungoides | 2.9% |
| 324 | Lymphomatoid Papulosis | 2.9% |
| 325 | Plasmablastic lymphoma | 2.9% |
| 326 | Meningeal Carcinomatosis | 2.8% |
| 327 | Pharyngeal Neoplasms | 2.5% |
| 328 | Burkitt Lymphoma | 2.5% |
| 329 | Central Nervous System Cysts | 2.5% |
| 330 | Bile Duct Neoplasms | 2.5% |
| 331 | gallbladder neoplasm | 2.5% |
| 332 | Intestinal Neoplasms | 2.5% |
| 333 | Penile Neoplasms | 2.5% |
| 334 | Prostatic Neoplasms | 2.5% |
| 335 | Stomach Neoplasms | 2.5% |
| 336 | Polycythemia Vera | 2.4% |
| 337 | Zollinger-Ellison syndrome | 2.4% |
| 338 | Bronchial Neoplasms | 2.3% |
| 339 | Multiple Pulmonary Nodules | 2.3% |
| 340 | Supratentorial Neoplasms | 2.3% |
| 341 | Endometrial Neoplasms | 2.2% |
| 342 | Laryngeal neoplasm | 2.2% |
| 343 | Bladder Neoplasm | 2.1% |
| 344 | Kidney Neoplasm | 2.1% |
| 345 | Ureteral Neoplasms | 2.1% |
| 346 | Urethral Neoplasms | 2.1% |
| 347 | Sezary Syndrome | 2.1% |
| 348 | Brain Stem Neoplasms | 1.9% |
| 349 | Hypopharyngeal Neoplasms | 1.9% |
| 350 | Pleural Effusion, Malignant | 1.9% |
| 351 | Hypopharyngeal Cancer | 1.9% |
| 352 | Parotid Neoplasms | 1.9% |
| 353 | Prostatic Neoplasms, Castration-Resistant | 1.9% |
| 354 | Nelson Syndrome | 1.9% |
| 355 | Choroid Plexus Papilloma | 1.8% |
| 356 | Cecal Neoplasms | 1.6% |
| 357 | Duodenal Neoplasms | 1.6% |
| 358 | Tonsillar Neoplasms | 1.6% |
| 359 | Cerebellar Neoplasms | 1.6% |
| 360 | Nasopharyngeal Neoplasms | 1.4% |
| 361 | Colorectal Neoplasms | 1.4% |
| 362 | Radicular Cyst | 1.4% |
| 363 | Appendiceal Neoplasms | 1.4% |
| 364 | Colonic Neoplasms | 1.4% |
| 365 | Rectal Neoplasms | 1.4% |
| 366 | Paranasal Sinus Neoplasms | 1.3% |
| 367 | Anus Neoplasms | 1.1% |
| 368 | Sigmoid Neoplasms | 1.1% |
| 369 | Maxillary Sinus Neoplasms | 1.1% |